[Federal Register Volume 69, Number 50 (Monday, March 15, 2004)]
[Notices]
[Page 12179]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-5778]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 20, 2004, Lin Zhi 
International, Inc., 687 North Pastoria Avenue, Sunnyvale, California 
94085, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below.

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
3,4-Methylenedioxymethamphetamine (7405)...  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Secobarbital (2315)........................  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Benzoylecgonine (9180).....................  II
Methadone (9250)...........................  II
Dextropropoxyphene (9273)..................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of controlled 
substances to make drug testing reagents and controls.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than May 14, 
2004.

    Dated: March 5, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-5778 Filed 3-12-04; 8:45 am]
BILLING CODE 4410-09-M